BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10382742)

  • 1. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro.
    Konecny P; Stagg AJ; Jebbari H; English N; Davidson RN; Knight SC
    Eur J Immunol; 1999 Jun; 29(6):1803-11. PubMed ID: 10382742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.
    von Stebut E; Belkaid Y; Jakob T; Sacks DL; Udey MC
    J Exp Med; 1998 Oct; 188(8):1547-52. PubMed ID: 9782133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process.
    Marovich MA; McDowell MA; Thomas EK; Nutman TB
    J Immunol; 2000 Jun; 164(11):5858-65. PubMed ID: 10820265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites.
    Courret N; Prina E; Mougneau E; Saraiva EM; Sacks DL; Glaichenhaus N; Antoine JC
    Eur J Immunol; 1999 Mar; 29(3):762-73. PubMed ID: 10092078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biogenesis of Leishmania major-harboring vacuoles in murine dendritic cells.
    Körner U; Fuss V; Steigerwald J; Moll H
    Infect Immun; 2006 Feb; 74(2):1305-12. PubMed ID: 16428780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection.
    Gorak PM; Engwerda CR; Kaye PM
    Eur J Immunol; 1998 Feb; 28(2):687-95. PubMed ID: 9521079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF.
    Saha B; Saini A; Germond R; Perrin PJ; Harlan DM; Davis TA
    Eur J Immunol; 1999 Jul; 29(7):2319-29. PubMed ID: 10427995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions.
    Liu D; Kebaier C; Pakpour N; Capul AA; Beverley SM; Scott P; Uzonna JE
    Infect Immun; 2009 Aug; 77(8):3272-83. PubMed ID: 19487470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKCδ regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis.
    Guler R; Afshar M; Arendse B; Parihar SP; Revaz-Breton M; Leitges M; Schwegmann A; Brombacher F
    Eur J Immunol; 2011 Mar; 41(3):706-15. PubMed ID: 21287553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major.
    Schnitzer JK; Berzel S; Fajardo-Moser M; Remer KA; Moll H
    Vaccine; 2010 Aug; 28(36):5785-93. PubMed ID: 20615489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of IL-2-induced T cell proliferation by a novel factor(s) present in murine spleen dendritic cell-T cell culture supernatants.
    Everson MP; Spalding DM; Koopman WJ
    J Immunol; 1989 Feb; 142(4):1183-94. PubMed ID: 2644351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection.
    Misslitz AC; Bonhagen K; Harbecke D; Lippuner C; Kamradt T; Aebischer T
    Eur J Immunol; 2004 Mar; 34(3):715-725. PubMed ID: 14991601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing.
    Vanloubbeeck YF; Ramer AE; Jie F; Jones DE
    Infect Immun; 2004 Aug; 72(8):4455-63. PubMed ID: 15271903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro.
    Bersudsky M; Apte RN; El-On J
    Exp Parasitol; 2000 Mar; 94(3):150-7. PubMed ID: 10831379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells.
    Belkaid Y; Butcher B; Sacks DL
    Eur J Immunol; 1998 Apr; 28(4):1389-400. PubMed ID: 9565379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity.
    Woelbing F; Kostka SL; Moelle K; Belkaid Y; Sunderkoetter C; Verbeek S; Waisman A; Nigg AP; Knop J; Udey MC; von Stebut E
    J Exp Med; 2006 Jan; 203(1):177-88. PubMed ID: 16418399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.